1. To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors

   • Cleo A. Samuel
   • Laura C. Pinheiro
   • Stephanie B. Wheeler

   Review 06 September 2016 Pages: 1 - 15

   

2. The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis

   • Michael J. Raphael
   • James J. Biagi
   • William J. Mackillop

   Review 08 September 2016 Pages: 17 - 28

   

3. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer

   • Julie O’Neal
   • Amy Clem
   • Brian F. Clem

   Preclinical study 09 September 2016 Pages: 29 - 40

   

4. Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy

   • John D. Hainsworth
   • Patrick B. Murphy
   • Denise A. Yardley

   Clinical Trial 08 September 2016 Pages: 41 - 49

   

5. ANG1005 for breast cancer brain metastases: correlation between ¹⁸F-FLT–PET after first cycle and MRI in response assessment

   • C. C. O’Sullivan
   • M. Lindenberg
   • S. E. Bates

   Clinical Trial 12 September 2016 Pages: 51 - 59

   

6. Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group

   • Shigeru Tsuyuki
   • Noriko Senda
   • Takashi Inamoto

   Clinical Trial 12 September 2016 Pages: 61 - 67

   

7. Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer

   • Juan Miguel Cejalvo
   • J. Alejandro Pérez-Fidalgo
   • Ana Lluch

   Clinical trial 14 September 2016 Pages: 69 - 77

   

8. Initial experience of the BREAST-Q breast-conserving therapy module

   • Rachel L. O’Connell
   • Rosa DiMicco
   • Jennifer E. Rusby

   Clinical trial 16 September 2016 Pages: 79 - 89

   

9. Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer

   • Stephen Johnston
   • Mark Basik
   • Massimo Cristofanilli

   Clinical Trial 21 September 2016 Pages: 91 - 99

   

10. Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy

    • Miho Kono
    • Takeo Fujii
    • Naoto T. Ueno

    Clinical trial 23 September 2016 Pages: 101 - 109

    

11. Trends and variation in the use of nipple-sparing mastectomy for breast cancer in the United States

    • Mark Sisco
    • Alexandra M. Kyrillos
    • Katharine A. Yao

    Epidemiology 12 September 2016 Pages: 111 - 120

    

12. Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2

    • Irene Catucci
    • Silvia Casadei
    • Susan L. Neuhausen

    Epidemiology 13 September 2016 Pages: 121 - 129

    

13. Long-term outcome in young women with breast cancer: a population-based study

    • Hanna Fredholm
    • Kristina Magnusson
    • Irma Fredriksson

    Epidemiology Open access 13 September 2016 Pages: 131 - 143

    

14. Ten-year survival in women with primary stage IV breast cancer

    • Lee Guek Eng
    • Shaheenah Dawood
    • Rebecca Dent

    Epidemiology 14 September 2016 Pages: 145 - 152

    

15. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient

    • Thomas M. Churilla
    • Brian L. Egleston
    • Richard J. Bleicher

    Epidemiology 17 September 2016 Pages: 153 - 162

    

16. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry

    • Akemi Kataoka
    • Takayuki Iwamoto
    • Yutaka Tokuda

    Epidemiology Open access 19 September 2016 Pages: 163 - 172

    

17. Analysis of the breast cancer methylome using formalin-fixed paraffin-embedded tumour

    • Ee Ming Wong
    • JiHoon E. Joo
    • Melissa C. Southey

    Brief Report 07 September 2016 Pages: 173 - 180

    

18. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations

    • Anna Sara Navazio
    • Piera Rizzolo
    • Laura Ottini

    Brief Report 15 September 2016 Pages: 181 - 186

    

19. Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

    • Vakaramoko Diaby
    • Georges Adunlin
    • Alberto J. Montero

    Brief Report 21 September 2016 Pages: 187 - 196